Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter

Molecular Immunology

Volumn 40, Issue 6, 2003, Pages 373-380

  Agrawal, Alok ^a   Samols, David ^b   Kushner, Irving ^b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

C reactive protein; C Rel; C EBP; NF B; Transcription factors

Indexed keywords

C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN; LUCIFERASE; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C REL; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0141756306     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00148-2     Document Type: Article

References (50)

1. Agrawal A., Cha-Molstad H., Samols D., Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interactions of CCAAT/enhancer binding protein β (C/EBPβ) and Rel p50. J. Immunol. 166:2001;2378-2384.
2. Agrawal A., Simpson M.J., Black S., Carey M.P., Samols D. A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide. J. Immunol. 169:2002;3217-3222.
3. Agresti A., Vercelli D. c-Rel is a selective activator of a novel IL-4/CD40 responsive element in the human Ig γ4 germline promoter. Mol. Immunol. 38:2001;849-859.
4. Baldwin A.S. Jr. The transcription factor NF-κB and human disease. J. Clin. Invest. 107:2001;3-6.
5. Bernard D., Slomianny C., Vandenbunder B., Abbadie C. c-Rel induces mitochondrial alterations in correlation with proliferation arrest. Free Radical Biol. Med. 31:2001;943-953.
6. Bernard D., Monte D., Vandenbunder B., Abbadie C. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene. 21:2002;4392-4402.
7. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
8. Brownell E., Mittereder N., Rice N.R. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene. 4:1989;935-942.
9. Campbell I.K., Gerondakis S., O'Donnell K., Wicks I.P. Distinct roles for the NF-(B1 κp50) and c-Rel transcription factors in inflammatory arthritis. J. Clin. Invest. 105:2000;1799-1806.
10. Castell J.V., Gomez-Lechon M.J., David M., Fabra R., Trullenque R., Heinrich P.C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 12:1990;1179-1186.
11. Cha-Molstad H., Agrawal A., Zhang D., Samols D., Kushner I. The rel family member p50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J. Immunol. 165:2000;4592-4597.
12. Diehl J.A., Hannink M. Identification of a C/EBP-Rel complex in avian lymphoid cells. Mol. Cell. Biol. 14:1994;6635-6646.
13. Fry C.J., Farnham P.J. Context-dependent transcriptional regulation. J. Biol. Chem. 274:1999;29583-29586.
14. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:1999;448-454.
15. Ganapathi M.K., May L.T., Schultz D., Brabenec A., Weinstein J., Sehgal P.B., Kushner I. Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem. Biophys. Res. Commun. 157:1988;271-277.
16. Ganapathi M.K., Rzewnicki D., Samols D., Jiang S.-L., Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep3B cells. J. Immunol. 147:1991;1261-1265.
17. Ganter U., Arcone R., Toniatti C., Morrone G., Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 8:1989;3773-3779.
18. Ghosh S., May M.J., Kopp E.B. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16:1998;225-260.
19. Gilmore T.D., Cormier C., Jeans-Jacques J., Gapuzan M.-E. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene. 20:2001;7098-7103.
20. + dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:2001;1021-1031.
21. Himes S.R., Coles L.S., Reeves R., Shannon M.F. High mobility group protein I (Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity. 5:1996;479-489.
22. Iwashima M., Takamatsu M., Yamagishi H., Hatanaka Y., Huang Y.-Y., McGinty C., Yamasaki S., Koike T. Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression. Proc. Natl. Acad. Sci. U.S.A. 99:2002;4544-4549.
23. Jiang S.-L., Samols D., Rzewnicki D., Macintyre S.S., Greber I., Sipe J., Kushner I. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J. Clin. Invest. 95:1995;1253-1261.
24. Kerr L.D., Ransone L.J., Wamsley P., Schmitt M.J., Boyer T.G., Zhou Q., Berk A.J., Verma I.M. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature. 365:1993;412-419.
25. Kleemann R., Gervois P.P., Verschuren L., Staels B., Princen H.M.G., Kooistra R. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NF-κB-C/EBPβ complex formation. Blood. 101:2003;545-551.
26. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1995;1965-1977.
27. Kushner I. The phenomenon of the acute phase response. Ann. N.Y. Acad. Sci. 389:1982;39-48.
28. Kushner I., Feldmann G. Control of the acute phase response: demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit. J. Exp. Med. 148:1978;466-477.
29. Li S.-P., Goldman N.D. Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements. Biochemistry. 35:1996;9060-9068.
30. Li S., Liu T.-Y., Goldman N.D. Cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. J. Biol. Chem. 265:1990;4136-4142.
31. Liu J., Beller D. Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-κB expression and binding to the IL-12 p40 promoter. J. Immunol. 169:2002;581-586.
32. Majello B., Arcone R., Toniatti C., Ciliberto G. Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J. 9:1990;457-465.
33. Martin A.G., Fresno M. Tumor necrosis factor-α activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J. Biol. Chem. 275:2000;24383-24391.
34. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:1995;5258-5267.
35. Pierce J.W., Jamieson C.A., Ross J.L., Sen R. Activation of IL-2 receptor α-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155:1995;1972-1980.
36. Pizzi M., Goffi F., Boroni F., Benarese M., Perkins S.E., Liou H.-C., Spano P. Opposing roles for NF-κB/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1β J. Biol. Chem. 277:2002;20717-20723.
37. 2 formation. J. Biol. Chem. 271:1996;31496-31501.
38. Sanjabi S., Hoffmann A., Liou H.-C., Baltimore D., Smale S.T. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. U.S.A. 97:2000;12705-12710.
39. Scherer D.C., Brockman J.A., Bendall H.H., Zhang G.M., Ballard D.W., Oltz E.M. Corepression of RelA and c-Rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes. Immunity. 5:1996;563-574.
40. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
41. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
42. Stein B., Cogswell P.C., Baldwin A.S. Jr. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:1993;3964-3974.
43. Tan T.-H., Huang G.P., Sica A., Ghosh P., Young H.A., Longo D.L., Rice N.R. κB site-dependent activation of the interleukin-2 receptor α-chain gene promoter by human c-Rel. Mol. Cell. Biol. 12:1992;4067-4075.
44. Vinson C.R., Sigler P.B., McKnight S.L. Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science. 246:1989;911-916.
45. Volanakis J.E. Human C-reactive protein: expression, structure and function. Mol. Immunol. 38:2001;189-197.
46. Weinhold B., Bader A., Poli V., Rüther U. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem. J. 325:1997;617-621.
47. Xu X., Gelinas C. A mutant Rel-homology domain promotes transcription by p50/NFκB1. Oncogene. 14:1997;1521-1530.
48. Xu X., Prorock C., Ishikawa H., Maldonado E., Ito Y., Gelinas C. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol. Cell. Biol. 13:1993;6733-6741.
49. Zhang D., Jiang S.-L., Rzewnicki D., Samols D., Kushner I. The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Biochem. J. 310:1995;143-148.
50. Zhang D., Sun M., Samols D., Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271:1996;9503-9509.